2025-07-15 - Analysis Report
Okay, here's an analysis of Intuitive Surgical (ISRG), incorporating the provided data points. The report is structured to first present key figures, followed by analysis and insights.

**Intuitive Surgical Inc (ISRG) Stock Analysis**

**1. Performance Overview & Comparative Analysis**

*   **Ticker:** ISRG
*   **Company Description:** Intuitive Surgical Inc. designs, manufactures, and markets robotic surgical systems and related instruments and accessories.
*   **Cumulative Return (ISRG):** 120.33%
*   **Cumulative Return (S&P 500 - VOO):** 95.85%
*   **Deviation:**
    *   Current Deviation: 28.3
    *   Max Deviation: 127.7
    *   Min Deviation: -6.8
    *   Relative Deviation: 26.1
    *   The current deviation of 28.3 suggests ISRG is outperforming the S&P 500. However, the relative deviation of 26.1 indicates that this outperformance is in the lower quartile of its historical range compared to VOO, implying that there's been periods where ISRG's outperformance was significantly higher.

*   **Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | 68.0%   | 56.5%   | 39.0%   | 0.0    | 43.6   |
| 2016-2018  | 77.0%   | 63.4%   | 59.0%   | 0.0    | 57.2   |
| 2017-2019  | 81.0%   | 63.4%   | 52.0%   | 0.3    | 70.6   |
| 2018-2020  | 47.0%   | 63.4%   | 28.0%   | 0.2    | 97.7   |
| 2019-2021  | 91.0%   | 63.0%   | 43.0%   | 0.2    | 128.8  |
| 2020-2022  | -3.0%   | 69.9%   | -6.0%   | 0.2    | 95.1   |
| 2021-2023  | -5.0%   | 72.9%   | -23.0%  | 0.9    | 120.9  |
| 2022-2024  | 26.0%   | 72.9%   | 0.0%    | 0.9    | 187.1  |
| 2023-2025  | 41.0%   | 72.9%   | -7.0%   | 0.7    | 185.1  |

*   **Analysis:**
    *   **CAGR & MDD:** CAGR (Compound Annual Growth Rate) varies significantly across the periods, indicating different growth phases. MDD (Maximum Drawdown) remains high, especially in recent years, signaling substantial risk.
    *   **Alpha:** The alpha values show ISRG's excess return relative to its benchmark. The alpha is decreasing and even negative in recent years.
    *   **Beta:** The beta values are low (0.0 to 0.3) initially, suggesting low correlation with the market, but have increased to 0.7-0.9, indicating a higher correlation with the market in recent periods.
    *   **Cap:** Market capitalization increased overall.

**2. Recent Price Action**

*   **Current Price:** 516.44
*   **Previous Close:** 512.06
*   **Change:** 0.86 (Positive, indicates a small price increase)
*   **Moving Averages:**
    *   5-day MA: 521.85
    *   20-day MA: 525.02
    *   60-day MA: 530.50
*   **Analysis:** The current price is below all three moving averages, suggesting a potential short-term downtrend or consolidation phase. The recent price increase is minor.

**3. Technical Indicators & Outlook**

*   **Market Risk Indicator (MRI):** 0.3372 (Low Risk)
*   **RSI:** 50.80 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.26 (Negative - suggesting a slight downtrend or consolidation)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33) (Cash Ratio: 0% on 2025-07-02)
*   **Relative Deviation Change (20-day):** -5.9 (Indicates a recent decrease in relative performance compared to the S&P 500)
*   **Expected Return:** 117.2% (Long-term, relative to S&P 500)
*   **Analysis:**
    *   MRI indicates low risk, but the Hybrid Signal advises caution, suggesting a potential divergence between broad market risk and stock-specific factors.
    *   The negative change in relative deviation is concerning.
    *   The high expected return suggests significant long-term potential, but it should be viewed cautiously, considering the recent negative trends.

**4. Recent News & Events**

*   **Summary of News:** The news suggests ISRG is experiencing volatility, driven by company-specific events, industry trends, and global economic factors. Analysts are actively discussing both risks and opportunities.
*   **Analysis:** This news indicates the stock is currently subject to increased scrutiny and potentially higher volatility. Investors should closely monitor company announcements and industry developments.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-04-23 | 1.95 | 2.25 B$    |
| 2024-10-18 | 1.59 | 2.04 B$    |
| 2024-07-19 | 1.48 | 2.01 B$    |
| 2024-04-19 | 1.54 | 1.89 B$    |
| 2025-04-23 | 1.54 | 1.89 B$    |

*   **Analysis:**
    *   The most recent EPS of 1.95 is the highest in the table.
    *   Revenue has generally been increasing over the observed quarters, except for 2025-04-23
    *   Double listing of 2025-04-23 seems to be a data error and should be clarified.

**6. Financial Information**

*   **Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $2.25B   | 64.69%        |
| 2024-12-31   | $2.41B   | 68.04%        |
| 2024-09-30   | $2.04B   | 67.41%        |
| 2024-06-30   | $2.01B   | 68.30%        |
| 2024-03-31   | $1.89B   | 65.87%        |

*   **Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-03-31   | $17.11B   | 4.08%   |
| 2024-12-31   | $16.43B   | 4.17%   |
| 2024-09-30   | $15.58B   | 3.63%   |
| 2024-06-30   | $14.71B   | 3.58%   |
| 2024-03-31   | $13.96B   | 3.90%   |

*   **Analysis:**
    *   **Revenue:** Revenue shows a general upward trend, with some fluctuations.
    *   **Profit Margin:** The profit margin is consistently high, indicating strong profitability.
    *   **Equity:** Equity has steadily increased, demonstrating growth in the company's net assets.
    *   **ROE:** Return on Equity (ROE) is relatively stable, indicating consistent profitability relative to equity.

**7. Overall Summary**

Intuitive Surgical (ISRG) exhibits strong fundamentals with high profit margins and increasing revenue and equity. The company has historically outperformed the S&P 500, although recent indicators suggest a possible short-term slowdown in relative performance. The technical indicators are mixed, with a neutral RSI and a slightly negative PPO. Recent news highlights increased volatility and scrutiny. While the long-term expected return remains high, the current market conditions warrant a cautious approach. The Hybrid Signal advising "Caution" reflects this uncertainty. Investors should closely monitor the company's earnings, news, and industry developments before making investment decisions.

In summary:

*   **Strengths:** Strong financials, high profitability, historical outperformance.
*   **Weaknesses:** Recent underperformance, increased volatility, decreasing Alpha.
*   **Outlook:** Cautiously optimistic, requires close monitoring.
